A recent study has found that STEAP3-AS1 downregulation could increase the expression of cyclin-dependent kinase inhibitor 1C (CDKN1C) by STEAP3 upregulation and modulate the cell cycle progression in CRC [41]. The gene discussed is CDKN1C; the disease is colorectal carcinoma.